MENU
+Compare
HYPMY
Stock ticker: OTC
AS OF
Jul 25 closing price
Price
$4.65
Change
-$0.22 (-4.52%)
Capitalization
5.79B

HYPMY Hypera SA Forecast, Technical & Fundamental Analysis

Hypera SA is a specialty and generic drug manufacturing company... Show more

HYPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HYPMY with price predictions
Jul 25, 2025

HYPMY in downward trend: price dove below 50-day moving average on July 25, 2025

HYPMY moved below its 50-day moving average on July 25, 2025 date and that indicates a change from an upward trend to a downward trend. In of 37 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HYPMY as a result. In of 116 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for HYPMY turned negative on July 11, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 60 similar instances when the indicator turned negative. In of the 60 cases the stock turned lower in the days that followed. This puts the odds of success at .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 76 cases where HYPMY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HYPMY advanced for three days, in of 244 cases, the price rose further within the following month. The odds of a continued upward trend are .

HYPMY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 242 cases where HYPMY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.476) is normal, around the industry mean (62.701). P/E Ratio (15.949) is within average values for comparable stocks, (88.783). HYPMY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.026) settles around the average of (0.122) among similar stocks. P/S Ratio (3.452) is also within normal values, averaging (18.372).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HYPMY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HYPMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
HYPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

HYPMY paid dividends on January 12, 2023

Hypera SA HYPMY Stock Dividends
А dividend of $0.06 per share was paid with a record date of January 12, 2023, and an ex-dividend date of December 29, 2022. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Avenida Magalhaes de Castro, 4800
Phone
N/A
Employees
7515
Web
https://www.hypermarcas.com.br
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PTMC35.200.31
+0.88%
Pacer Trendpilot™ US Mid Cap ETF
IMCG82.770.72
+0.88%
iShares Morningstar Mid-Cap Growth ETF
CEFD19.370.10
+0.53%
ETRACS Monthly Pay 1.5X Lvgd CE Fd ETN
QIG44.63N/A
N/A
WisdomTree US Corporate Bond
SPDN10.05-0.04
-0.40%
Direxion Daily S&P 500® Bear 1X ETF

HYPMY and Stocks

Correlation & Price change

A.I.dvisor tells us that HYPMY and HKMPY have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HYPMY and HKMPY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPMY
1D Price
Change %
HYPMY100%
-4.52%
HKMPY - HYPMY
14%
Poorly correlated
N/A
KHTRF - HYPMY
8%
Poorly correlated
+0.10%
JUSHF - HYPMY
8%
Poorly correlated
+9.15%
HKMPF - HYPMY
7%
Poorly correlated
N/A
IPSEY - HYPMY
7%
Poorly correlated
-1.75%
More